| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
837 |
712 |
$97K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,051 |
927 |
$87K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
979 |
882 |
$79K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
877 |
780 |
$50K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,289 |
1,177 |
$47K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
447 |
398 |
$24K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
228 |
189 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
176 |
162 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
143 |
84 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
25 |
25 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
691 |
629 |
$1K |
| 99000 |
|
2,115 |
1,934 |
$870.66 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
25 |
24 |
$842.16 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16 |
13 |
$518.76 |
| 99072 |
|
2,134 |
1,940 |
$60.00 |